Literature DB >> 7964192

Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE.

F Karpe1, A Hamsten.   

Abstract

The present work describes a procedure for determining apolipoproteins (apo) B-100 and B-48 in subfractions of triglyceride-rich lipoproteins by analytical sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) with Coomassie staining. The chromogenicity of the two apoB species was found to be almost equal, and independent of lipoprotein particle size. Both proteins were sensitive to overloading of the gel, which resulted in low dye uptake. This was particularly evident for apoB-48. The precision of this analytical SDS-PAGE-based procedure to determine the plasma concentrations of apoB-100 and B-48 in triglyceride-rich lipoproteins was found to be appreciably low (coefficients of variation ranging between 3.1 and 14.1%).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964192

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  16 in total

1.  Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48.

Authors:  A Curtin; P Deegan; D Owens; P Collins; A Johnson; G H Tomkin
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

2.  Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.

Authors:  N Matikainen; S Mänttäri; A Schweizer; A Ulvestad; D Mills; B E Dunning; J E Foley; M-R Taskinen
Journal:  Diabetologia       Date:  2006-07-01       Impact factor: 10.122

3.  Postdinner resistance exercise improves postprandial risk factors more effectively than predinner resistance exercise in patients with type 2 diabetes.

Authors:  Timothy D Heden; Nathan C Winn; Andrea Mari; Frank W Booth; R Scott Rector; John P Thyfault; Jill A Kanaley
Journal:  J Appl Physiol (1985)       Date:  2014-12-24

4.  The isolation and functional identification on producing cellulase of Pseudomonas mendocina.

Authors:  Jianfeng Zhang; Hongyan Hou; Guang Chen; Shusheng Wang; Jiejing Zhang
Journal:  Bioengineered       Date:  2016-09-02       Impact factor: 3.269

5.  Comparison of diets high in monounsaturated versus polyunsaturated fatty acid on postprandial lipoproteins in diabetes.

Authors:  C Madigan; M Ryan; D Owens; P Collins; G H Tomkin
Journal:  Ir J Med Sci       Date:  2005 Jan-Mar       Impact factor: 1.568

6.  Postprandial lipemia in the elderly involves increased incorporation of ingested fat in plasma free fatty acids and small (Sf 20-400) triglyceride-rich lipoproteins.

Authors:  Guilherme M Puga; Christian Meyer; Sarah Everman; Lawrence J Mandarino; Christos S Katsanos
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-10       Impact factor: 4.310

7.  Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.

Authors:  B Eliasson; D Möller-Goede; K Eeg-Olofsson; C Wilson; J Cederholm; P Fleck; M Diamant; M-R Taskinen; U Smith
Journal:  Diabetologia       Date:  2012-01-12       Impact factor: 10.122

8.  Mobilisation of enterocyte fat stores by oral glucose in humans.

Authors:  M D Robertson; M Parkes; B F Warren; D J P Ferguson; K G Jackson; D P Jewell; K N Frayn
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

9.  Postprandial lipemia is modified by the presence of the APOB-516C/T polymorphism in a healthy Caucasian population.

Authors:  Pablo Pérez-Martínez; Francisco Pérez-Jiménez; José María Ordovás; Juan Antonio Moreno; Carmen Marín; Rafael Moreno; Yolanda Jiménez-Gómez; Juan Antonio Paniagua; José López-Miranda
Journal:  Lipids       Date:  2007-02-10       Impact factor: 1.880

10.  Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein.

Authors:  S Lally; C Y Tan; D Owens; G H Tomkin
Journal:  Diabetologia       Date:  2006-03-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.